Venture capital financing within healthtech has fallen 41.2% compared to the same time last year. The Asia-Pacific region had the largest year-on-year decrease (-64.8%), followed by Europe (-45.8%), and North America (-38.7%). In contrast, funding for the Middle East and Africa, and South and Central America markets grew by 158.7% and 16.4%, respectively. North America remains the largest funding market, accounting for approximately 70% of all VC deals in healthtech.
The global fall in VC activity follows a surge in investment in the years before and amid the pandemic, which saw the total deal value grow by 132% from 2015 to 2020, Medical Device Network reports.
The top five themes within the healthtech sector, as identified by GlobalData’s Deal Database, include artificial intelligence (AI), big data, digital media, digitalisation, and the Internet of Things (IoT). Read more.
